Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutics of multiple sclerosis.

J H Noseworthy1

  • 1Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905.

Clinical Neuropharmacology
|February 1, 1991
PubMed
Summary

Current multiple sclerosis (MS) treatments are inadequate. Comprehensive patient support and participation in clinical trials are crucial for managing MS and its complications effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disability as an outcome in MS clinical trials.

Neurology·2008
Same author

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Neurology·2005
Same author

Disability profile of MS did not change over 10 years in a population-based prevalence cohort.

Neurology·2004
Same author

Change in MS-related disability in a population-based cohort: a 10-year follow-up study.

Neurology·2004
Same author

Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000.

Neurology·2003
Same author

International consensus statement on the use of disease-modifying agents in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2002

Area of Science:

  • Neurology
  • Clinical Medicine

Background:

  • Multiple Sclerosis (MS) treatment remains a significant challenge.
  • Current therapeutic strategies offer limited efficacy for many patients.
  • Holistic patient care addressing emotional and social needs is vital.

Purpose of the Study:

  • To review the current state of multiple sclerosis (MS) management.
  • To highlight the importance of supportive care and patient education.
  • To evaluate the role of existing and experimental therapies.

Main Methods:

  • Review of existing literature on MS treatment and management.
  • Analysis of the efficacy of immunosuppressive drugs and corticosteroids.
  • Emphasis on the role of multidisciplinary healthcare teams.

Main Results:

  • Evidence for significant impact of immunosuppressive drugs on MS natural history is limited.
  • Corticosteroids may offer benefits for some patients but require cautious use.
  • Management of MS complications can be achieved with varying success.

Conclusions:

  • Multidisciplinary support and patient education are essential for MS care.
  • Participation in controlled clinical trials is recommended for progressive MS.
  • Further research is needed to understand disease activity and develop definitive treatments.

Related Experiment Videos